Canada accounts for just 4% of the world’s clinical trials—a modest share compared to the United States’ 20% contribution. But considering Canada’s population is only a fraction of the U.S., their clinical research presence is actually quite significant.
Right now, there is a growing push from Canada to streamline research and development. Meanwhile, there is volatility in U.S. markets. More sponsors are beginning to ask: Could Canada play a bigger role in global clinical research?
In this outlook report, you will learn:
- The current state of clinical trials in Canada
- What sets Canada apart from other regions
- How sponsors can leverage Canada’s advantages to strengthen multinational strategies
- Whether the recent increase in activity signals a temporary trend or a lasting transformation
Contributing Experts at Medrio:
- Tina Caruana, Director of eClinical Solutions